- Home
- OIS vs SPRY Comparison
OIS vs SPRY Comparison
Compare OIS & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OIS | SPRY |
|---|---|---|
| Founded | 1995 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 552.6M | 509.4M |
| IPO Year | 2000 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OIS | SPRY |
|---|---|---|
| Price | $9.00 | $6.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $14.00 | ★ $40.00 |
| AVG Volume (30 Days) | 629.8K | ★ 2.4M |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $1,088,133,000.00 | $84,278,000.00 |
| Revenue This Year | $3.12 | $87.40 |
| Revenue Next Year | $5.89 | $81.64 |
| P/E Ratio | $76.33 | ★ N/A |
| Revenue Growth | ★ 62.26 | N/A |
| 52 Week Low | $4.93 | $4.91 |
| 52 Week High | $14.50 | $15.09 |
Technical Indicators
Market Signals| Indicator | OIS | SPRY |
|---|---|---|
| Relative Strength Index (RSI) | 59.66 | 51.72 |
| Support Level | $8.60 | $4.91 |
| Resistance Level | $11.86 | $8.61 |
| Average True Range (ATR) | 0.40 | 0.42 |
| MACD | 0.09 | 0.18 |
| Stochastic Oscillator | 88.14 | 98.20 |
Price Performance
Historical ComparisonAbout OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to customers in the energy, military and industrial sectors. The company operates through three business segments - Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. Its customers include many national oil and natural gas companies, and independent oil and natural gas companies, offshore drilling companies and other oilfield service, defense and industrial companies.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.